Hospital
Steward NSMC, INC.
Steward NSMC, INC. was paid $3.53M by Medicaid between May 2021 and Nov 2024, across 127 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.
33Billing provider infoSTEWARD NSMC, INC.
LAUDERDALE LAKES, FL 33313
LAUDERDALE LAKES, FL 33313
33aNPI1891367629assigned 07/12/2021
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.53M
24GClaims150,465
24DCodes billed127
24AFirst – last monthMay 2021 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#96 of 163
Median peer was paid$4.77M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 30,853 | $638K | |
| 2022 | 68,919 | $1.61M | |
| 2023 | 34,828 | $850K | |
| 2024incomplete | 15,865 | $426K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 8,991 | 7,203 | $1.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 8,154 | 6,592 | $794K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 6,830 | 5,369 | $777K |
| 70450 | Computed tomography, head or brain; without contrast material | 8.7% | 1,160 | 936 | $306K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.7% | 552 | 507 | $200K |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 2.6% | 266 | 53 | $91K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 783 | 659 | $75K |
| G0378 | Hospital observation service, per hour | 1.8% | 4,017 | 1,622 | $62K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,098 | 1,569 | $35K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 180 | 148 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,608 | 1,068 | $19K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 189 | 163 | $16K |
115 more codes
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 28 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 759 | $12K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 5,415 | $7K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 270 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 595 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,552 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,961 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,380 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,949 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 9,570 | $3K |
| 97162 | <1% | 167 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,561 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 533 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 137 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,458 | $2K |
| 85610 | <1% | 1,508 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 114 | $2K |
| 86850 | <1% | 464 | $2K | |
| 86901 | <1% | 464 | $2K | |
| 86900 | <1% | 464 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,280 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 37 | $1K |
| 73564 | <1% | 81 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 429 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,728 | $1K |
| 72131 | <1% | 17 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,799 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,868 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,055 | $1K |
| 85730 | <1% | 1,313 | $915.21 | |
| 81025 | <1% | 4,279 | $702.66 | |
| 96376 | <1% | 979 | $522.23 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,236 | $503.58 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 543 | $502.35 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 357 | $489.37 |
| 84484 | <1% | 2,542 | $389.94 | |
| A9270 | Non-covered item or service | <1% | 1,020 | $306.91 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 68 | $298.28 |
| 87081 | <1% | 316 | $286.64 | |
| 80050 | General health panel | <1% | 44 | $279.51 |
| 82550 | <1% | 843 | $265.02 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 252 | $257.43 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 465 | $255.52 |
| 82962 | <1% | 2,114 | $225.20 | |
| 83690 | <1% | 1,340 | $189.05 | |
| 81001 | <1% | 3,736 | $156.20 | |
| 84702 | <1% | 1,199 | $152.57 | |
| 84439 | <1% | 17 | $133.10 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 80 | $126.57 |
| 87070 | <1% | 728 | $112.66 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 90 | $75.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 149 | $71.05 |
| 94664 | <1% | 249 | $70.24 | |
| 99001 | <1% | 156 | $67.61 | |
| 76801 | <1% | 228 | $65.29 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 24 | $65.29 |
| 73610 | <1% | 30 | $64.23 | |
| 74018 | <1% | 284 | $55.31 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,839 | $49.26 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,496 | $45.92 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 66 | $33.34 |
| S0028 | Injection, famotidine, 20 mg | <1% | 293 | $25.74 |
| 83880 | <1% | 529 | $20.53 | |
| 85027 | <1% | 433 | $20.03 | |
| 83735 | <1% | 946 | $15.97 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 151 | $14.08 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 93 | $14.08 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 866 | $9.75 |
| 81003 | <1% | 588 | $6.63 | |
| 87040 | <1% | 683 | $4.55 | |
| 86140 | <1% | 17 | $3.53 | |
| 80061 | Lipid panel | <1% | 24 | $2.67 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,491 | $2.54 |
| 87430 | <1% | 359 | $2.28 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 221 | $2.28 |
| 84100 | <1% | 180 | $1.57 | |
| 72170 | 0% | 17 | $0.00 | |
| 83605 | 0% | 443 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 171 | $0.00 |
| 85379 | 0% | 242 | $0.00 | |
| 87808 | 0% | 147 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 576 | $0.00 |
| 87077 | 0% | 428 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 698 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 39 | $0.00 |
| 87205 | 0% | 421 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 14 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 391 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 82 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 158 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 478 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 197 | $0.00 |
| 85651 | 0% | 35 | $0.00 | |
| 80047 | 0% | 14 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 27 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 68 | $0.00 |
| 87807 | 0% | 56 | $0.00 | |
| 84703 | 0% | 35 | $0.00 | |
| J1212 | Injection, dmso, dimethyl sulfoxide, 50%, 50 ml | 0% | 16 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 17 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 331 | $0.00 |
| 85045 | 0% | 157 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 230 | $0.00 |
| 80076 | 0% | 99 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 1,018 | $0.00 |
| 90714 | 0% | 31 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 109 | $0.00 |
| 80143 | 0% | 41 | $0.00 | |
| 87186 | 0% | 443 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 480 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 125 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 97 | $0.00 |
| 97116 | 0% | 66 | $0.00 | |
| 72100 | 0% | 16 | $0.00 | |
| 80179 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLTZ, HERBERT (OFFICER, DIRECTOR, GENERAL COUNSEL)
Parent organizationSTEWARD NSMC, INC.
| Provider | Location | Paid |
|---|---|---|
| Steward NSMC, INC. | Miami, FL | $5.76M |
| Steward PGH, INC. | Hialeah, FL | $5.50M |
| Steward HH. INC. | Hialeah, FL | $5.16M |
| Steward CGH, INC. | Coral Gables, FL | $2.40M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.